mus eluting-stent (SES) implantation, whereas the same change after BMS implantation was not seen before 2 years and remained a rare finding until 4 years. 8, 9 Second-generation DES have further improved the safety and similar efficacy compared with first-generation DES. 10,11 Recently, Otsuka et al reported from an autopsy study in human coronary arteries that cobalt chromium everolimus-eluting stents (CoCr-EES) yielded a lower inflammation score without any hypersensitivity and less fibrin deposition than first-generation SES and paclitaxeleluting stents, while the frequency of neoatherosclerosis was comparable among them. 12 Those findings indicate that in-stent neoatherosclerosis remains an unsolved issue even in the era of second-generation DES. To date, however, the mechanism and temporal course of ISR after secondgeneration DES implantation have not yet been fully evaluated, so we used OCT in the present study to evaluate the F irst-generation drug-eluting stents (DES), which inhibit intimal hyperplasia, have dramatically reduced the rate of in-stent restenosis (ISR) and subsequent target lesion revascularization (TLR) within the first year of stent implantation compared with baremetal stents (BMS). 1,2 However, in real-world practice, late adverse events such as very late stent thrombosis (VLST) and late TLR beyond 1 year have emerged as unsolved issues after first-generation DES implantation. 3 Previous optical coherence tomography (OCT) studies have reported that the mechanism and temporal course of ISR differ between BMS and first-generation DES. 4-7 Although in-stent neoatherosclerosis has been suggested as a cause of late adverse events with both BMS and firstgeneration DES, pathological studies demonstrated that the earliest atherosclerotic change with foamy macrophage infiltration began at 4 months after first-generation siroli- The mechanism and time course of in-stent restenosis (ISR) after implantation of second-generation DES have not yet been fully elucidated. We sought to evaluate the differences in tissue characteristics between the different phases of ISR after second-generation DES implantation using optical coherence tomography (OCT).